Novartis (NVS) total liabilities

Total liabilities · fiscal 2025
$64.40B

Novartis (NVS) had total liabilities of $64.40B at the end of fiscal 2025 (December 31, 2025). That is 10.8% higher than the $58.12B of fiscal 2024. Figures as of 18 Nov 2026, 20:58 UTC, from Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$64.40B
Change on fiscal 2024
+10.8%
Highest on record
$64.40Bfiscal 2025
Lowest on record
$53.20Bfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Novartis total liabilities, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $64.40B in fiscal 2025 and the lowest $53.20B in fiscal 2023.

History · 4 fiscal years

Total liabilities by fiscal year

Novartis total liabilities, year by year

Novartis (NVS) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$64.40B 10.8% up
2024$58.12B 9.3% up
2023$53.20B 8.3% down
2022$58.03B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Novartis and comparable companies
CompanyTotal liabilitiesFiscal year
AbbVie ABBV$137.19B2025
Merck & Co MRK$84.20B2025
UnitedHealth Group UNH$207.88B2025
Novartis NVS$64.40B2025
AstraZeneca AZN$65.36B2025
Thermo Fisher Scientific TMO$56.81B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVS

Novartis, figure by figure

Novartis (NVS) overview: price, valuation and scorecardAll health care companies by market value

Novartis total liabilities: questions and answers

How large are Novartis's total liabilities?

Novartis (NVS) had total liabilities of $64.40B at the end of fiscal 2025 (December 31, 2025). That is 10.8% higher than the $58.12B of fiscal 2024.

What are the highest and lowest total liabilities figures on record for Novartis?

Across the 4 fiscal years on record (2022–2025), the highest was $64.40B in fiscal 2025 and the lowest $53.20B in fiscal 2023.

How is Novartis's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Novartis it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novartis (NVS) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/total-liabilities

Underlying data: Yahoo Finance.